Abbott Laboratories
Ads
related to: abbvie pharmaceuticalsSee What AbbVie Does To Make An Impact On Patients' Lives. Learn About What We Care About. Find The Company's Mission, Principles & Culture. See What We Do Beyond Treating Diseases.
- AbbVie News Center
See Our Achievements, Growth Story,
and More Today.
- Read AbbVie Stories
Read Stories About Our Science,
People, and More Today.
- Our Science
See How We Impact Lives.
More Than Developing Medicines.
- Investor Resources
Find Financial Reports, Stock Info
And More Resources For Investors.
- AbbVie News Center
Regulatory intelligence for more than 150 countries, supporting you around the globe. Small Molecule APIs, Large Molecule Biologics, API's & Intermediates, SIs, and OSDs.
Search results
May 7, 2024 · AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives.
- Join Us
As a result, the site may contain information on...
- Products
employees turning possibilities into reality for people and...
- Investor Overview
AbbVie discovers, develops, and commercializes advanced...
- Who We Are
AbbVie was founded in 2013 when we became a separate company...
- Pipeline
Pipeline | AbbVie. Science. Pipeline. Advanced medicines...
- Partner with Us
AbbVie Neuroscience portfolio consists of approved therapies...
- Patient Support
AbbVie help patients get the medicines and solutions they...
- Latest News
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration...
- Media Contacts
gabrielle.tarbert@abbvie.com or...
- Events and Presentations
AbbVie cautions that these forward-looking statements are...
- Join Us
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74.
Mar 25, 2024 · March 25, 2024. AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases. Landos' lead asset, NX-13, is a first-in-class, oral NLRX1 agonist in Phase 2 for the treatment of ulcerative colitis (UC)
Dec 6, 2023 · NORTH CHICAGO, Ill. and CAMBRIDGE, Mass., Dec. 6, 2023 / PRNewswire / -- AbbVie Inc. (NYSE: ABBV) and Cerevel Therapeutics (NASDAQ: CERE) today announced a definitive agreement under which AbbVie will acquire Cerevel Therapeutics and its robust neuroscience pipeline of multiple clinical-stage and preclinical candidates with potential across seve...
News about AbbVie, earnings estimate revisions, Cosmo Pharmaceuticals
News about Cencora, data breach, Lash Group
Also in the news
People also ask
Where is AbbVie headquartered?
What does AbbVie do?
Is AbbVie acquiring cerevel Therapeutics?
Did AbbVie buy Pharmacyclics & AstraZeneca?
Ads
related to: abbvie pharmaceuticalsSee What AbbVie Does To Make An Impact On Patients' Lives. Learn About What We Care About. Find The Company's Mission, Principles & Culture. See What We Do Beyond Treating Diseases.
Regulatory intelligence for more than 150 countries, supporting you around the globe. Small Molecule APIs, Large Molecule Biologics, API's & Intermediates, SIs, and OSDs.
Types:
